Sylvester Joins Consortium to Preserve Fertility in Cancer Patients
Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, recently joined the Oncofertility Consortium, a national, interdisciplinary initiative designed to explore the reproductive future of cancer survivors. More than 220 universities and cancer centers from around the globe are members of the Consortium, including Northwestern University, Duke University, UC San Diego, and Mayo Clinic.
“My Sylvester colleagues and I are very pleased to be joining the Oncofertility Consortium,” said Julio C. Barredo, M.D., Director of the Division of Pediatric Hematology-Oncology at Sylvester. “The Consortium provides us with the opportunity to partner with colleagues from around the globe in an effort to reduce infertility rates after cancer treatment in pediatric and young adult patients.”
The risk of infertility is a common concern for both women and men after cancer therapy, especially in younger patients who plan on having children once their cancer treatment is complete. Together with teams of cancer experts at Sylvester, Consortium members will collaborate to study the effects of cancer treatments on fertility and how to overcome reproductive obstacles.
“Under the umbrella of the Oncofertility Consortium, made up of a multidisciplinary team of pediatric and adult oncologists, male and female fertility specialists, urology and gynecologic oncology physicians, Sylvester patients will have access to state-of-the-art fertility preservation services,” said Barredo. “As cure rates for cancer patients continue to improve, oncofertility services are critical to our pediatric, adolescent and young adult patients, as well as all other patients at reproductive age.”
Click here to learn more about the Oncofertility Consortium.